Repositorio Institucional de la Universidad de Oviedo

Combination of an HMG-COA reductase inhibitor and a Farnesyl-pyrophosphatase synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins

Author:

Levy, Nicolas; Cau, Pierre; López Otín, Carlos

Publication date:

2015-09-23

URI:

http://hdl.handle.net/10651/43239

Número de solicitud:

PT20070803849T

Número de la patente:

PT2034985 (E)